126 related articles for article (PubMed ID: 22888654)
1. [The role of age and tumor grade in the choice of fractionation regimen in patients with high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2012; 58(3):374-9. PubMed ID: 22888654
[TBL] [Abstract][Full Text] [Related]
2. [The role of functional status and recursive partition analysis (RPA) classes for the choice of fractionation regimen in patients with high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2012; 58(3):369-73. PubMed ID: 22888653
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation the effectiveness of radiation therapy high-grade gliomas based on the model of TDF (time-dose fractionation)].
Izmaĭlov TR; Pan'shin GA; Misliukov SM; Datsenko PV
Vopr Onkol; 2013; 59(5):629-35. PubMed ID: 24260893
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
5. Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (Rapid Arc) for reradiation in recurrent high grade gliomas.
Anand AK; Kumar P; Patir R; Vaishya S; Bansal AK; Chaudhoory AR; Punnakal AU; Malhotra H; Munjal RK
J Cancer Res Ther; 2014; 10(1):97-102. PubMed ID: 24762494
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
7. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.
Fitzek MM; Thornton AF; Harsh G; Rabinov JD; Munzenrider JE; Lev M; Ancukiewicz M; Bussiere M; Hedley-Whyte ET; Hochberg FH; Pardo FS
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):131-7. PubMed ID: 11516862
[TBL] [Abstract][Full Text] [Related]
8. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
9. Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma.
Jones B; Sanghera P
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):441-8. PubMed ID: 17324531
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas.
Farzin M; Molls M; Astner S; Rondak IC; Oechsner M
Strahlenther Onkol; 2015 Dec; 191(12):945-52. PubMed ID: 26340939
[TBL] [Abstract][Full Text] [Related]
11. Fractionated Radiotherapy of Intracranial Gliomas.
Ghia AJ
Prog Neurol Surg; 2018; 31():38-47. PubMed ID: 29393175
[TBL] [Abstract][Full Text] [Related]
12. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D
J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609
[TBL] [Abstract][Full Text] [Related]
13. Transition from 2D conventional to 3d conformal radiation therapy in patients with brain gliomas: clinical outcome (Mansoura University).
Awad IA; El-Kholi NM; El-Lithy MA; Hendawi EA; Anter AH
J Egypt Natl Canc Inst; 2009 Jun; 21(2):133-8. PubMed ID: 21057564
[TBL] [Abstract][Full Text] [Related]
14. Volumetric response evaluation after intensity modulated radiotherapy in patients with supratentorial gliomas.
Cho KH; Choi JH; Kim JY; Lee SH; Yoo H; Shin KH; Kim TH; Moon SH; Lee SH; Park HC
Technol Cancer Res Treat; 2012 Feb; 11(1):41-8. PubMed ID: 22181330
[TBL] [Abstract][Full Text] [Related]
15. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.
Brada M; Thomas G; Elyan S; James N; Hines F; Ashley S; Marsh H; Bell BA; Stenning S
Br J Cancer; 1995 Jun; 71(6):1330-4. PubMed ID: 7779733
[TBL] [Abstract][Full Text] [Related]
16. Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study.
Siker ML; Firat SY; Mueller W; Krouwer H; Schultz CJ
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):765-72. PubMed ID: 21236600
[TBL] [Abstract][Full Text] [Related]
17. Integral dose delivered to normal brain with conventional intensity-modulated radiotherapy (IMRT) and helical tomotherapy IMRT during partial brain radiotherapy for high-grade gliomas with and without selective sparing of the hippocampus, limbic circuit and neural stem cell compartment.
Marsh JC; Ziel GE; Diaz AZ; Wendt JA; Gobole R; Turian JV
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):378-83. PubMed ID: 23721150
[TBL] [Abstract][Full Text] [Related]
18. Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.
Brada M; Sharpe G; Rajan B; Britton J; Wilkins PR; Guerrero D; Hines F; Traish D; Ashley S
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):287-92. PubMed ID: 10030251
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques.
Rubino G; Sacco P; Cerase A; Volterrani L; Sebaste L; Pepi F; Pirtoli L
Radiol Med; 2004; 107(1-2):128-35. PubMed ID: 15031704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
